SDTM IG - Then and Now

Size: px
Start display at page:

Download "SDTM IG - Then and Now"

Transcription

1 SDTM IG - Then and Now Updates from version to Presented at DCDISC 25-Jul Jul-2013

2 Changes New Variables for Human Trials and SEND Incorporation of Amendment 1 Changes to Trial Design Other Changes Oncology Domains SDTM Oncology Sub-team Activities

3 New Variables : DM RFXSTDTC Date/Time of 1st Study Trt (exp) RFXENDTC Date/Time of Last Study Trt (exp) RFICDTC Date/Time of Informed Consent (exp) RFPENDTC Date/Time of End Participation (exp) DTHDTC Date/Time of Death (exp) DTHFL Subject Death Flag (exp) AGETXT Age RangeText SPECIES Species STRAIN Strain/Substrain Substrain SBSTRAIN Strain/Substrain Substrain Details ACTARMCD Actual Arm Code (req req) ACTARM Description of Actual Arm (req req) SETCD Set Code

4 Code List for ACTARMCD/ACTARM SCRNFAIL / 'Screen Failure' = Screen failures NOTASSGN / 'Not Assigned' = Subjects not assigned to treatment UNPLAN / 'Unplanned Treatment' = Arm is not planned (not in Trial Arms) NOTTRT / 'Not Treated' = Randomized subjects who were not treated

5 New Variables : Events --LLTCD Lowest Level Term Code (exp) --PTCD Preferred Term Code (exp) --HLT High Level Term (exp) --HLTCD High Level Term Code (exp) --HLGT High Level Group Term (exp) --HLGTCD High Level Group Term Code (exp) --BDSYCD Body System or Organ Class Code (exp) --SOC Primary System Organ Class (exp) --SOCCD Primary System Organ Class Code (exp)

6 New Variables : Findings --ANTREG Anatomical Region --SPCUFL Specimen Usability for the Test --LAT Laterality --DIR Directionality --PORTOT Distribution (Portion or Totality) --LEAD Lead Identified to Collect Measurements --CSTATE Consciousness State --EVALID Evaluator Specified --ACPTFL Accepted Record Flag --EXCLFL Exclude from Statistics --REASEX Reason for Exclusion from Statistics --DTHREL Related to Death

7 New Variables : Timing and Identifiers --DETECT Time in Days to Detection of a condition/pathogen POOLID Pool Identifier --LNKID Link ID --LNKGRP Link Group ID

8 New Variables : Trial Summary TSVALNF Parameter Null Flavor TSVALCD Parameter Value Code TSVCDREF Name of the Reference Terminology TSVCDVER Version of the Reference Terminology

9 Amendment 1 Changes MedDRA Terms added to Events --TRTEM (Treatment Emergent Flag) not included New DM variables added

10 Changes to Trial Design New variables for TS Addition of NULL FLAVOR for TS New Codes for TS

11 TS: Trial Summary

12 TS: Trial Summary

13 TS: Null Flavor Embodied in the ISO standard, Health Informatics Harmonized data types for information exchange An ancillary piece of data that provides additional information when its primary piece of data is null (has a missing value) Uses Controlled Terminology Test for future use in other domains

14 TS: Null Flavor No information Invalid Other Positive infinity Negative infinity Unencoded Derived Unknown Asked but unknown Temporarily unavailable Not asked Quantity sufficient Trace Masked Not applicable

15 TS: Null Flavor

16 TS: Null Flavor TSVALNF contains a null flavor, a value that provides additional coded information when TSVAL is null. TSPARM = MAXAGE, there is no value if a study does not specify a maximum age. In this case, the appropriate null flavor is PINF, which stands for positive infinity. For a drug which indications are not yet established, the appropriate null flavor for TINDC would be NA, which stands for not applicable.

17 TS: Null Flavor

18 Other: Variable Lengths Maximum character length 200 Maximum flag length 1 --TESTCD and IDVAR maximum length is 8 Maximum length of variables with control terminology is length of longest term

19 Other: AE/MH Coding --DECOD = Preferred Term --BODSYS = SOC used in primary analysis --SOC = Dictionary defined primary SOC If MedDRA used, provide all intermediate levels

20 Other: CM Coding CMDECOD = Drug s s generic name CMCLAS = Drug s s class used for analysis and reporting Additional coding dictionary qualifiers go to SUPPQUAL (e.g. ACT Codes)

21 Oncology Domains TU Tumor Identification TR Tumor Results RS Disease Results Originally developed based RECIST criteria SDTM Oncology Sub-Team working to expand usage

22 Oncology Domains TU Tumor Identification Used to uniquely identify tumors, classify them, identify location, how/who identified them Per RECIST: Target Non-Target New Tumor Handles new, splits and merges Uses --LNKID to identify and relate tumors

23 TUMIDENT Control Terminology

24 TUTESTCD Control Terminology

25 Oncology Domains TR Tumor Results Contains quantitative measurements / qualitative assessments of tumors in TU TRTESTCD/TRTEST uses Control Terminology no derivations by sponsor If too small use criteria lower limit (5mm) TRACPTFL only used if multiple evaluators User TREVALID/TREVAL to identify evaluators

26 TRTESTCD Control Terminology

27 Oncology Domains RS Disease Results Contains response evaluations as determined from results in TR Use --LNKGRP to link with TR domain RSTESTCD/RSTEST uses Control Terminology no derivations by sponsor RSCAT identifies criteria/clinical ASSESSMENT RSACPTFL only used if multiple evaluators User RSEVALID/RSEVAL to identify evaluators

28 RSTESTCD Control Terminology

29 RSSTRESC Control Terminology

30 TU Example

31 TR Example

32 TU Example (split/merge/new)

33 TR Example (split/merge/new)

34 RS Example

35 RELREC Example

36 SDTM Oncology Sub-team Activities Control Terminology Updates Response versus Remission New TRTESTs Collect Response Criteria (90+) MO vs. TR for Liver/Spleen Measurements RU for Assessments w/o Targets End of Study/Trt using DSSCAT (death as outcome) Review CV Usage of TU/TR

On the Horizon: New Trial Summary Dataset (TS)

On the Horizon: New Trial Summary Dataset (TS) On the Horizon: New Trial Summary Dataset (TS) Helena Sviglin, Chris Tolk, and Jane Diefenbach DCDISC Meeting at HGSI, Gaithersburg MD November 8, 2011 Presenting. Overview What is it? Where did it come

More information

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China ABSTRACT Study Data Tabulation Model (SDTM) is an evolving global standard which is widely used for regulatory submissions. The automation of SDTM programming is essential to maximize the programming efficiency

More information

Study Data Reviewer s Guide Completion Guideline

Study Data Reviewer s Guide Completion Guideline Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on

More information

The New SDTMIG What s Different from Previous Versions

The New SDTMIG What s Different from Previous Versions 1 The New SDTMIG 3.1.4 What s Different from Previous Versions Presented by Dan Godoy (SDS Team Co-Lead) 2 Agenda Background Progress-to-Date SDTM 3.1.4 - What s Different? Key Features & Examples Q&A

More information

Updates on CDISC Standards Validation

Updates on CDISC Standards Validation Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation

More information

Common Programming Errors in CDISC Data

Common Programming Errors in CDISC Data ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards

More information

Applying ADaM Principles in Developing a Response Analysis Dataset

Applying ADaM Principles in Developing a Response Analysis Dataset PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium

More information

PharmaSUG China 2018 Paper CD-09

PharmaSUG China 2018 Paper CD-09 PharmaSUG China 2018 Paper CD-09 Every Second Counts! Save Time on Developing Trial Summary Specification Mei Chu, PAREXEL International, Taipei, Taiwan Kyle Chang, PAREXEL International, Taipei, Taiwan

More information

Hanming Tu, Accenture, Berwyn, USA

Hanming Tu, Accenture, Berwyn, USA Hanming Tu, Accenture, Berwyn, USA Agenda Issue Statement Create Mapping Build Reusable Codes Define Repeatable Workflow Check compliance Conclusion Copyright 2016 Accenture. All rights reserved. 2 Issue

More information

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk

IS03: An Introduction to SDTM Part II. Jennie Mc Guirk IS03: An Introduction to SDTM Part II Jennie Mc Guirk SDTM Framework 1. Where should the data go? 3. What is the minimum information needed? 2. What type of information should it contain? SDTM Framework:

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data

More information

DIA 11234: CDER Data Standards Common Issues Document webinar questions

DIA 11234: CDER Data Standards Common Issues Document webinar questions Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect

More information

Application of SDTM Trial Design at GSK. 9 th of December 2010

Application of SDTM Trial Design at GSK. 9 th of December 2010 Application of SDTM Trial Design at GSK Veronica Martin Veronica Martin 9 th of December 2010 Contents SDTM Trial Design Model Ti Trial ldesign datasets t Excel Template for Trial Design 2 SDTM Trial Design

More information

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES Developing Integrated Summary of Safety Database using CDISC Standards Rajkumar Sharma, Genentech Inc., A member of the Roche Group, South San Francisco, CA ABSTRACT Most individual trials are not powered

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

More information

NCI/CDISC or User Specified CT

NCI/CDISC or User Specified CT NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or

More information

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Pooling Clinical Data: Key points and Pitfalls October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Introduction Are there any pre-defined rules to pool clinical data? Are there any pre-defined

More information

The application of SDTM in a disease (oncology)-oriented organization

The application of SDTM in a disease (oncology)-oriented organization Paper CD01 The application of SDTM in a disease (oncology)-oriented organization Angelo Tinazzi, Alessandro Cattaneo, Enrica Paschetto, Sonia Colombini SENDO-Tech S.r.l., Milan, Italy ABSTRACT Applying

More information

Considerations on creation of SDTM datasets for extended studies

Considerations on creation of SDTM datasets for extended studies 13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation

More information

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.

More information

Study Data Reviewer s Guide

Study Data Reviewer s Guide Revision History Date Study Data Reviewer s Guide Completion Guideline: Nonclinical (nnsdrg) Version Summary V1.1 03 March 2016 1.0 First Public Version: posted for Public Comment 1.1 Update from Public

More information

Standardising The Standards The Benefits of Consistency

Standardising The Standards The Benefits of Consistency Paper DH06 Standardising The Standards The Benefits of Consistency Nathan James, Roche Products Ltd., Welwyn Garden City, UK ABSTRACT The introduction of the Study Data Tabulation Model (SDTM) has had

More information

SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC

SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC PharmaSUG 2016 - Paper PO21 SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC ABSTRACT Much has been written about automatically creating outputs for the

More information

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Dealing with changing versions of SDTM and Controlled Terminology (CT) CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards

More information

WISER. Protocol Creation, Activation, and Management TRAINING MANUAL. Wake Integrated Solution for Enterprise Research. For Oncology Studies

WISER. Protocol Creation, Activation, and Management TRAINING MANUAL. Wake Integrated Solution for Enterprise Research. For Oncology Studies WISER Wake Integrated Solution for Enterprise Research Protocol Creation, Activation, and Management For Oncology Studies TRAINING MANUAL Version June 11, 2018 WELCOME to WISER! Navigation and Home Page

More information

Office of Human Research

Office of Human Research Office of Human Research JeffTrial End-User Training Document Regulatory Coordinator Training for Non-Oncology personnel Office of Human Research 8/16/2013 Ver. 1.0 Contents The REG Role: Completing Basic

More information

RELREC - SDTM Programmer's Bermuda Triangle

RELREC - SDTM Programmer's Bermuda Triangle PharmaSUG 2017 - Paper DS09 RELREC - SDTM Programmer's Bermuda Triangle Charumathy Sreeraman, Ephicacy Lifescience Analytics Pvt. Ltd., Bangalore, India ABSTRACT The CDISC Study Data Tabulation Model (SDTM)

More information

Mapping and Terminology. English Speaking CDISC User Group Meeting on 13-Mar-08

Mapping and Terminology. English Speaking CDISC User Group Meeting on 13-Mar-08 Mapping and Terminology English Speaking CDISC User Group Meeting on 13-Mar-08 Statement of the Problem GSK has a large drug portfolio, therefore there are many drug project teams GSK has standards 8,200

More information

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,

More information

ADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter

ADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter ADaM IG v1.1 & ADaM OCCDS v1.0 Dr. Silke Hochstaedter 1 Agenda What s new in Analysis Data Model Implementation Guide Version 1.1 The new ADaM Structure for Occurrence Data (OCCDS) Version 1.0 Q&A ADaM

More information

Ophthalmic Examinations (OE) Domain Overview and Status

Ophthalmic Examinations (OE) Domain Overview and Status Ophthalmic Examinations (OE) Domain Overview and Status Marcelina Hungria, Sub-team Lead on behalf of the SDS Ophthalmology Sub-team, 2014-09-17 Preparing for Public Review OE Domain - Agenda Project Background

More information

PharmaSUG Paper DS24

PharmaSUG Paper DS24 PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,

More information

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies

More information

Introduction of Semantic Technology for SAS programmers Kevin Lee, Clindata Insight, Moraga, CA

Introduction of Semantic Technology for SAS programmers Kevin Lee, Clindata Insight, Moraga, CA Introduction of Semantic Technology for SAS programmers Kevin Lee, Clindata Insight, Moraga, CA ABSTRACT There is a new technology to express and search the data that can provide more meaning and relationship

More information

esubmission - Are you really Compliant?

esubmission - Are you really Compliant? ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle

More information

Introduction to ADaM and What s new in ADaM

Introduction to ADaM and What s new in ADaM Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis

More information

What is high quality study metadata?

What is high quality study metadata? What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study

More information

Study Data Tabulation Model Implementation Guide: Human Clinical Trials Version 3.2. Prepared by the CDISC Submission Data Standards Team

Study Data Tabulation Model Implementation Guide: Human Clinical Trials Version 3.2. Prepared by the CDISC Submission Data Standards Team Study Data Tabulation Model Implementation Guide: Human Clinical Trials Version 3.2 Prepared by the CDISC Submission Data Standards Team Notes to Readers This is the implementation guide for Human Clinical

More information

Data Consistency and Quality Issues in SEND Datasets

Data Consistency and Quality Issues in SEND Datasets Data Consistency and Quality Issues in SEND Datasets PointCross has reviewed numerous SEND datasets prepared for test submissions to the FDA and has worked with the FDA on their KickStart program to ensure

More information

DF/HCC Operations for Human Research Subject Registration Procedures

DF/HCC Operations for Human Research Subject Registration Procedures 1. BACKGROUND: This document outlines the appropriate procedures for subject registration and other registration situations that may arise. To quickly locate a specific topic, please use the hyperlinks

More information

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets PharmaSUG 2017 - Paper SS09 Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets Xiangchen (Bob) Cui, Min Chen, and Letan (Cleo) Lin, Alkermes Inc.,

More information

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015 PMDA Valida+on Rules Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency Max Kanevsky December 10, 2015 Presenter Max Kanevsky Founder of OpenCDISC CEO of Pinnacle

More information

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges

More information

OnCore Enterprise Research. Subject Administration Full Study

OnCore Enterprise Research. Subject Administration Full Study OnCore Enterprise Research Subject Administration Full Study Principal Investigator Clinical Research Coordinator June 2017 P a g e 1 This page is intentionally blank. P a g e 2 Table of Contents What

More information

CS05 Creating define.xml from a SAS program

CS05 Creating define.xml from a SAS program CS05 Creating define.xml from a SAS program Jørgen Mangor Iversen LEO Pharma A/S 21 November 2013 LEO Pharma About LEO Pharma A/S Independent, research-based pharmaceutical company Founded in 1908 Employs

More information

JeffTrial Training Document Protocol Management. Jefferson Coordinating Center for Clinical Research 9/10/2013 Ver. 1.1

JeffTrial Training Document Protocol Management. Jefferson Coordinating Center for Clinical Research 9/10/2013 Ver. 1.1 JeffTrial Training Document Protocol Management Jefferson Coordinating Center for Clinical Research 9/10/2013 Ver. 1.1 Table of Contents JCCCR Process Flow Diagram... 3 The REG Role, PART I: Entering Basic

More information

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits

More information

Change Request Information

Change Request Information Change Request Information Acknowledgements Acknowledgements MedDRA trademark is owned by IFPMA on behalf of ICH. Microsoft and Excel are registered trademarks of Microsoft Corporation in the United States

More information

How to clean up dirty data in Patient reported outcomes

How to clean up dirty data in Patient reported outcomes Paper DH02 How to clean up dirty data in Patient reported outcomes Knut Mueller, UCB Schwarz Biosciences, Monheim, Germany ABSTRACT The current FDA Guidance for Industry - Patient Reported Outcome Measures

More information

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies 23 January 2013 EMA/48663/2013 Patient Health Protection Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies Introduction From 10 January

More information

***** ***** August

***** ***** August SLU eirb Conversion Charts Saint Louis University ***** eirb Paper to Electronic Protocol Conversion Charts ***** Institutional Review Board August 2011 http://eirb.slu.edu Institutional Review Board Saint

More information

Implementation of Data Cut Off in Analysis of Clinical Trials

Implementation of Data Cut Off in Analysis of Clinical Trials PharmaSUG 2018 DS19 Implementation of Data Cut Off in Analysis of Clinical Trials Mei Dey, AstraZeneca, USA Ann Croft, ARC Statistical Services Ltd, UK ABSTRACT Interim analysis can result in key decisions

More information

How to handle different versions of SDTM & DEFINE generation in a Single Study?

How to handle different versions of SDTM & DEFINE generation in a Single Study? Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,

More information

VigiFlow. User Guide. for version 5.2. Consult release notes for updates in 5.3

VigiFlow. User Guide. for version 5.2. Consult release notes for updates in 5.3 VigiFlow User Guide for version 5.2 Consult release notes for updates in 5.3 UMC the Uppsala Monitoring Centre Box 1051 SE-751 40 Uppsala SWEDEN visiting address: Bredgränd 7, Uppsala, Sweden phone: +46-18

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM Ajay Gupta, PPD INTRODUCTION + TIBCO Spotfire is an analytics and business intelligence platform, which enables data visualization in

More information

Implementing CDISC Using SAS. Full book available for purchase here.

Implementing CDISC Using SAS. Full book available for purchase here. Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models

More information

PharmaSUG Paper PO21

PharmaSUG Paper PO21 PharmaSUG 2015 - Paper PO21 Evaluating SDTM SUPP Domain For AdaM - Trash Can Or Buried Treasure Xiaopeng Li, Celerion, Lincoln, NE Yi Liu, Celerion, Lincoln, NE Chun Feng, Celerion, Lincoln, NE ABSTRACT

More information

Main challenges for a SAS programmer stepping in SAS developer s shoes

Main challenges for a SAS programmer stepping in SAS developer s shoes Paper AD15 Main challenges for a SAS programmer stepping in SAS developer s shoes Sebastien Jolivet, Novartis Pharma AG, Basel, Switzerland ABSTRACT Whether you work for a large pharma or a local CRO,

More information

A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov

A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov SESUG Paper AD-127-2017 A Macro for Generating the Adverse Events Summary for ClinicalTrials.gov Andrew Moseby and Maya Barton, Rho, Inc. ABSTRACT In the clinical trials industry, the website ClinicalTrials.gov

More information

Implementing CDISC at Boehringer Ingelheim

Implementing CDISC at Boehringer Ingelheim Paper CD03 Implementing CDISC at Boehringer Ingelheim Michael Knoessl, Boehringer Ingelheim, Ingelheim, Germany Peter Leister, IBM, Hamburg, Germany ABSTRACT The Study Data Tabulation Model (SDTM), as

More information

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc.

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc. PharmaSUG2011 - Paper DM03 Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc., TX ABSTRACT In the Clinical trials data analysis

More information

Study Data Tabulation Model Implementation Guide: Human Clinical Trials Prepared by the CDISC Submission Data Standards Team

Study Data Tabulation Model Implementation Guide: Human Clinical Trials Prepared by the CDISC Submission Data Standards Team Study Data Tabulation Model Implementation Guide: Human Clinical Trials Prepared by the CDISC Submission Data Standards Team Notes to Readers This is the approved implementation guide for Version 1 of

More information

JeffTrial Training Document Coordinator Training. Thomas Jefferson University 1/15/2016 Ver. 2.0

JeffTrial Training Document Coordinator Training. Thomas Jefferson University 1/15/2016 Ver. 2.0 JeffTrial Training Document Coordinator Training Thomas Jefferson University 1/15/2016 Ver. 2.0 Table of Contents Clinical Study Process Flow Diagram... 4 Navigation... 5 Getting Started... 5 User Roles...

More information

OPEN v8.1 Site User Guide Revision 14

OPEN v8.1 Site User Guide Revision 14 CTSU Cancer Trials Support Unit Revision 14 December 7, 2017 Overview of OPEN Document Information Revision Information for the Revision History # Date By Description 1.0 19-SEP-2013 Mark Stauffer Updated

More information

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA Paper FC02 SDTM, Plus or Minus Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT The CDISC Study Data Tabulation Model (SDTM) has become the industry standard for the regulatory submission

More information

National metadata repository for databases of registers and trials

National metadata repository for databases of registers and trials National metadata repository for databases of registers and trials IBE, Medical Faculty, Ludwig-Maximilians-Universität München, Germany Institute for Medical Informatics (IMISE), Universität Leipzig,

More information

JeffTrial Subject Registration Clinical Coordinator Training. Kimmel Cancer Center JeffTrials version 13.0 Ver. 1.2

JeffTrial Subject Registration Clinical Coordinator Training. Kimmel Cancer Center JeffTrials version 13.0 Ver. 1.2 JeffTrial Subject Registration Clinical Coordinator Training Kimmel Cancer Center 1.2.14 JeffTrials version 13.0 Ver. 1.2 Coordinator Register a Patient 1. Log in to JeffTrial https://jefftrial.tjh.tju.edu/login

More information

Challenges with the interpreta/on of CDISC - Who can we trust?

Challenges with the interpreta/on of CDISC - Who can we trust? Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

JMP Clinical. Release Notes. Version 5.0

JMP Clinical. Release Notes. Version 5.0 JMP Clinical Version 5.0 Release Notes Creativity involves breaking out of established patterns in order to look at things in a different way. Edward de Bono JMP, A Business Unit of SAS SAS Campus Drive

More information

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AGENDA 1. Motivation 2. Automation Overview 3. Architecture 4. Validating the System 5. Pilot Study Results 6. Future State Copyright 2012-2017

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection

More information

STUDY DATA TECHNICAL CONFORMANCE GUIDE

STUDY DATA TECHNICAL CONFORMANCE GUIDE STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions

More information

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide

Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Paper DS06 Best Practice for Explaining Validation Results in the Study Data Reviewer s Guide Kristin Kelly, Pinnacle 21 LLC, Plymouth Meeting, PA, USA Michael Beers, Pinnacle 21 LLC, Plymouth Meeting,

More information

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT

More information

Study Data Tabulation Model

Study Data Tabulation Model Study Data Tabulation Model Prepared by the CDISC Submission Data Standards Team Principal Editor: Principal Contributors: Wayne Kubick Fred Wood, Diane Wold, Tom Guinter, Julie Evans, CDISC SDS Team Notes

More information

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort

More information

Reviewers Guide on Clinical Trials

Reviewers Guide on Clinical Trials Reviewers Guide on Clinical Trials Office of Research Integrity & Compliance Version 2 Updated: June 26, 2017 This document is meant to help board members conduct reviews for Full Board: Clinical Trial

More information

!"# $ # # $ $ % $ &% $ '"# $ ()&*&)+(( )+(( )

!# $ # # $ $ % $ &% $ '# $ ()&*&)+(( )+(( ) !"# # # % &% '"# ) !#, ' "# " "# -. / # 0 0 0 0 0 "0 "# " # 1 #! " " 0 0 0 0 0 0 2# 0 # # 3 ' 4 56 7-56 87 9# 5 6 7 6 & 0 " : 9 ; 4 " #! 0 - '% # % "# " "# " < 4 "! % " % 4 % % 9# 4 56 87 = 4 > 0 " %!#

More information

Knock Knock!!! Who s There??? Challenges faced while pooling data and studies for FDA submission Amit Baid, CLINPROBE LLC, Acworth, GA USA

Knock Knock!!! Who s There??? Challenges faced while pooling data and studies for FDA submission Amit Baid, CLINPROBE LLC, Acworth, GA USA PharmaSUG China 2018 Paper CD-03 Knock Knock!!! Who s There??? Challenges faced while pooling data and studies for FDA submission Amit Baid, CLINPROBE LLC, Acworth, GA USA ABSTRACT Pooling studies is not

More information

OC RDC 4.6. User Guide

OC RDC 4.6. User Guide OC RDC 4.6 Read-Only User Guide Version 1.0 Page 1 of 25 TABLE OF CONTENTS ACCESSING OC RDC...3 Steps for Obtaining Access...3 Logging On...4 Password Changes...5 Computer System and Security...5 VIEWING

More information

Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis Prepared by the CDISC Analysis Data Model Team Notes to Readers This Analysis model uses the principles, structure and standards described

More information

USING HASH TABLES FOR AE SEARCH STRATEGIES Vinodita Bongarala, Liz Thomas Seattle Genetics, Inc., Bothell, WA

USING HASH TABLES FOR AE SEARCH STRATEGIES Vinodita Bongarala, Liz Thomas Seattle Genetics, Inc., Bothell, WA harmasug 2017 - Paper BB08 USING HASH TABLES FOR AE SEARCH STRATEGIES Vinodita Bongarala, Liz Thomas Seattle Genetics, Inc., Bothell, WA ABSTRACT As part of adverse event safety analysis, adverse events

More information

Extending SMQ Hierarchies in TMS Defining Filter Dictionary Structures to Allow Maximum, Flexible Design for Customized SMQs

Extending SMQ Hierarchies in TMS Defining Filter Dictionary Structures to Allow Maximum, Flexible Design for Customized SMQs Extending SMQ Hierarchies in TMS Defining Filter Dictionary Structures to Allow Maximum, Flexible Design for Customized SMQs Bill Caulkins Sunil Singh Denise Clark DBMS Consulting, Inc. 12 October 2010

More information

SAS Online Training: Course contents: Agenda:

SAS Online Training: Course contents: Agenda: SAS Online Training: Course contents: Agenda: (1) Base SAS (6) Clinical SAS Online Training with Real time Projects (2) Advance SAS (7) Financial SAS Training Real time Projects (3) SQL (8) CV preparation

More information

User Guide 16-Mar-2018

User Guide 16-Mar-2018 16-Mar-2018 This document is freely distributable Identification Authors Name Organization Title TMF User Guide and Implementation Guide Sub-Team Version History Version Steering Committee Approval Date

More information

CRF Design for Data Standards. David A. Scocca

CRF Design for Data Standards. David A. Scocca CRF Design for Data Standards David A. Scocca dave_scocca@rhoworld.com CRF Design for Data Standards Controlled Terminology Epochs and Dispositions Dates and Times Free Text Fields Avoiding Unwanted Data

More information

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

Metadata and ADaM.

Metadata and ADaM. Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata

More information

OpenCDISC Validator 1.4 What s New?

OpenCDISC Validator 1.4 What s New? OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation

More information

SDTM-ETL 4.0 Preview of New Features

SDTM-ETL 4.0 Preview of New Features SDTM-ETL 4.0 Preview of New Features Author: Jozef Aerts, XML4Pharma Last update: 2018-12-01 Automated installation of new or additional SDTM/SEND templates When new versions of the SDTM-IG or SEND-IG

More information

Generating Define.xml from Pinnacle 21 Community

Generating Define.xml from Pinnacle 21 Community PharmaSUG 2018 - Paper AD-29 ABSTRACT Generating Define.xml from Pinnacle 21 Community Pinky Anandani Dutta, Inclin, Inc Define.xml is an XML document that describes the structure and contents (metadata

More information

ectd Next Major Version Business Requirements (11-JUN-09)

ectd Next Major Version Business Requirements (11-JUN-09) ICH Req No. ICH01 ICH02 ICH03 ICH04 TOPIC APPLICATION APPLICATION APPLICATION APPLICATION ectd Next Major Version Business Requirements (11-JUN-09) Requirement A regulated product application may have

More information

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.

More information

Material covered in the Dec 2014 FDA Binding Guidances

Material covered in the Dec 2014 FDA Binding Guidances Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material

More information

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the

More information

WISER. Wake Integrated Solution for Enterprise Research. Protocol Creation, Activation, and Management. For Non-Oncology Studies.

WISER. Wake Integrated Solution for Enterprise Research. Protocol Creation, Activation, and Management. For Non-Oncology Studies. WISER Wake Integrated Solution for Enterprise Research Protocol Creation, Activation, and Management For Non-Oncology Studies Version 6/11/2018 TRAINING MANUAL WELCOME to WISER! Navigation and Home Page

More information